Diabetes mellitus type 2. Diabetes mellitus
Conditions
Interventions
Intervention 1: In the first group Pioglitazone 30 mg daily as the third drug will be used. Intervention 2: In the second group Sytaglyptyn 100 mg daily medicine as the third drug will be used.
Treatment - Drugs
In the first group Pioglitazone 30 mg daily as the third drug will be used.
In the second group Sytaglyptyn 100 mg daily medicine as the third drug will be used.
Sponsors
Vice Chancellor for Research of Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Diabetics Type II; taking complete doze of Metformin (1500-2000mg) and a Sulfonylurea (15-20mg); age range from 30 to 65; 7% = HbAlc; Reluctance to take insulin; willingness to participate in the study. Exclusion criteria: pregnant patient; patients with heart failure; patients with renal insufficiency; patients with bladder cancer background; Glycemic severe complications including DKA; Reluctance to participate in the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood sugar. Timepoint: Before treatment and three months after starting the drug. Method of measurement: Test.;HbA1C. Timepoint: Before treatment and three months after starting the drug. Method of measurement: Test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Nasser Aghmohammadzadeh
Tabriz University of Medical Sciences
Outcome results
None listed